<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9835083</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Robles García, J E</dc:author>
<dc:author>Martín-Marquina Aspiunza, A</dc:author>
<dc:author>Rosell Costa, D</dc:author>
<dc:author>Berián Polo, J M</dc:author>
<dc:author>Arocena García-Tapia, J</dc:author>
<dc:author>Rodríguez-Rubio Cortadellas, F</dc:author>
<dc:author>Zudaire Bergera, J J</dc:author>
<dc:author>Sanz Pérez, G</dc:author>
<dc:author>Díaz-Caballero Alonso, F</dc:author>
<dc:description xml:lang="en">Retrospective study of 107 patients diagnosed with infiltrant tumour of the bladder in stage T3-T4 N0-N1, treated with radical surgery. Eighty-four (84) received neoadjuvant therapy with radio- and/or chemotherapy. The neoadjuvant treatment was seen to provide significantly better survival, but the specific type of neoadjuvant treatment appears to have no influence. The multivariate study evidenced that the two most influential variables for survival are the complementary treatment and the clinical stage.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1998 Sep </dc:date>
<dc:title xml:lang="es">Influencia del tratamiento neoadjuvante en los tumores infiltrantes de vejiga tratados con cistectomía radical.</dc:title>
<dc:title xml:lang="en">[Influence of neoadjuvant treatment on bladder infiltrating tumors treated with radical cystectomy].</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
